PLDT Inc. (PHI)
Last Price$24.70.5%
Market Cap$5,353.8M
PHI Rating
PHI Quality rating performance
PHI Intrinsic Value
Key Highlights:
As of Mar 07, 2025 PHI Relative Value is $28.2, which is undervalued by 14.1%, compared to current share price of $24.7.
As of Mar 07, 2025 PHI DCF Value is N/A, which is undervalued by N/A, compared to current share price of $24.7.
PHI Share Price History
1W 8.5%
1M 7.6%
6M (5.6%)
YTD 10.5%
1Y 12.9%
3Y (17.6%)
5Y 65.2%
10Y (44.2%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
PHI Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$5,353.8M
$10.7B
₱215.5B
₱20.6B
Shares Outstanding
216M
Employees
N/A
Growth (CAGR)
5.1%
7.55%
27.1%
29.39%
Profitability
71.5%
19.8%
12.4%
36.6%
9.6%
69.0%
Intrinsic Value
$28.2 (14.0% undervalued)
N/A
$28.2
92.3%
Return on Capital
Financial Health
₱309.9B
15.0x
5.3x
286.2%
Dividends
11.2%
6.7%
100.5%
Aug 26, 2024
Earnings
Mar 25, 2025
BEAT by 0.1%
MISS by (9.9%)
(10.3%)
5 Beat & 5 Miss
PHI Stock Financials
PHI Income Statement Metrics
Annual
Quarterly
LTM
PHI Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$1,538.6M +8.3% YoY
Capital Expenditure (CAPEX)
($1,407.1M) -18.5% YoY
Free Cash Flow (FCF)
$131.5M N/A YoY
PHI Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$3,784.6M 2.8% YoY
Cost of revenue
$1,000.8M 170.5% YoY
Pre-tax income
$654.4M 170.0% YoY
17.3% margin
PHI Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$11.0B
Current assets ($1,262.9M, 11.5% of total)
$307.8M (2.8%)
$494.8M (4.5%)
Other current assets
$460.4M (4.2%)
Non-current assets ($9,714.5M, 88.5% of total)
$986.3M (9.0%)
$5,760.0M (52.5%)
$25.1M (0.2%)
Other non-current assets
$2,943.2M (26.8%)
Financial position
$5,137.5M
Cash & Short-term
Investments
Total Debt
PHI Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
PHI Earnings Surprises
Crunching data... Almost there!
PHI Dividends
PHI Dividend Yield
Crunching data... Almost there!
PHI Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with PHI
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$5,353.8M | 7.2 | $28.2 14.0% undervalued | 12.9% | ₱215.5B | ₱20.6B | 3.3% | 9.6% | 71.5% | 9.3% | 286.2% | |
$310.1B | 7.5 | $88.2 66.7% overvalued | 63.1% | $81.4B | $9,982.0M | 3.6% | 12.3% | 55.1% | 7.8% | 184.6% | |
$195.3B | 5.7 | $22.3 17.9% overvalued | 68.3% | $122.3B | $18.5B | (0.1%) | 15.1% | 59.8% | 5.5% | 119.2% | |
$194.3B | 6.1 | $108.2 135.0% undervalued | 24.4% | $134.8B | $18.9B | 0.6% | 14.0% | 59.9% | 7.1% | 167.4% | |
$144.4B | 6.1 | $71.3 89.7% undervalued | (7.1%) | $123.7B | $13.5B | 1.8% | 10.9% | 64.1% | 9.9% | 5.7% | |
$53.9B | 6.5 | $511.2 34.7% undervalued | 34.6% | $55.1B | $3,161.0M | 0.9% | 5.7% | 55.0% | 16.4% | 476.6% | |
$45.7B | 5.8 | $66.8 349.7% undervalued | (19.1%) | MX$833.0B | MX$54.2B | 0.2% | 6.5% | 61.8% | 11.5% | 158.5% | |
$30.4B | 5.4 | $46.6 19.1% undervalued | 5.0% | NT$190.3B | NT$46.1B | (13.4%) | 24.2% | 18.9% | 8.6% | 11.3% | |
$27.4B | 6.6 | $26.6 158.9% undervalued | (8.7%) | €73.8B | €4,707.0M | (1.1%) | 6.4% | 46.4% | 21.9% | 25.1% | |
$25.6B | 6.6 | $72.4 668.5% undervalued | 12.4% | €63.0B | €24.8B | (30.7%) | 39.3% | 32.3% | 6.4% | 95.4% | |
$25.6B | 5.9 | $17.4 284.0% undervalued | 14.9% | €41.3B | €5,093.0M | 1.6% | 12.3% | 72.0% | 3.7% | 197.9% |
FAQ
What is PLDT Inc. (PHI) stock rating?
As of today, PLDT Inc. has a stock rating of 7 (out of 10), which is considered Great.
is PLDT Inc. (PHI) a good stock to buy?
As of today, PLDT Inc. has a Great stock rating, which is 14.0% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.